Icosavax Q3 EPS $(0.44) Beats $(0.57) Estimate
Portfolio Pulse from Benzinga Newsdesk
Icosavax (NASDAQ:ICVX) reported a Q3 EPS loss of $(0.44), surpassing the analyst consensus estimate of $(0.57) by 22.81%. The reported loss shows a 20% improvement from the $(0.55) per share loss in the same quarter of the previous year.
November 14, 2023 | 9:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Icosavax reported a smaller-than-expected loss per share for Q3, beating estimates and showing year-over-year improvement.
Beating EPS estimates typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. The improvement over last year's loss per share further strengthens the positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100